The impact of comorbidity identification on outcomes in patients with pyoderma gangrenosum: A retrospective cohort study of previously hospitalized patients

J Am Acad Dermatol. 2022 Jul;87(1):194-197. doi: 10.1016/j.jaad.2021.07.032. Epub 2021 Jul 24.

Authors

Manisha Ravi¹, John Trinidad², Natalie Spaccarelli², Benjamin Kaffenberger³

Affiliations

¹ Ohio State University College of Medicine, Columbus, Ohio.
² Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
³ Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: benjamin.kaffenberger@osumc.edu.

PMID: 34314745
DOI: 10.1016/j.jaad.2021.07.032

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Comorbidity
Humans
Inflammatory Bowel Diseases* / epidemiology
Pyoderma Gangrenosum* / diagnosis
Pyoderma Gangrenosum* / epidemiology
Retrospective Studies